Provider review
Coby Health review
Charges by the dose — and measures its discount against the dose above.
A genuine per-dose ladder billed monthly, cheapest at 0.25 mg/week and rising with each dose band. The struck-through figure beside the entry price is the 0.50 mg price, not a former price of the rung it sits on.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Coby Health
$159/mo at 0.25 mg/wk semaglutide
- Vs median
- $10/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Quotes off the lowest dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Coby does the thing this site most often looks for and rarely finds: it charges less for less. The semaglutide ladder rises across four price bands from 0.25 mg/week to 2.4 mg, with a milligram figure printed against every rung, and the month-to-month tab is honestly labeled — it says "Billed monthly" and "No subscription required", so the headline is not a prepay rate dressed as one. That combination is uncommon enough to put it near the best options here on structure alone. Two things pull against it. The saving it advertises is not what it appears: the bundle block strikes through a higher figure beside the entry price, but that figure is not a price Coby used to charge for 0.25 mg — it is what Coby charges today for 0.50 mg, so the discount is displayed against a higher dose than the one being bought. And the terms undercut the marketing: they state in capitals that any applicable fees and other charges are not refundable in whole or in part, which is a different proposition from the flexibility the product page implies. Five FAQ answers on the semaglutide page are still placeholder Lorem ipsum, one of them the answer to whether a subscription is required.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You intend to stay at a low dose and want the bill to reflect that — this is one of the few ladders here where it genuinely does
- You want the milligram figure printed against the price rather than inferred from a plan name
- You want a month-to-month option that is actually month-to-month, stated as such on the page
- You already know you will hold one dose for a quarter, which is what the three-month same-dose prepay rung is built for
Look elsewhere if
- You are comparing advertised savings across providers — the discount shown here is measured against a higher dose, so it is not comparable to a genuine price cut
- You want the option of a refund if you stop: the terms rule it out in whole or in part, in capitals
- You want the dispensing pharmacy named — none is published on any page checked
- You judge a provider by whether its own FAQ is finished; five answers here are still Lorem ipsum
What it actually costs
Price as published
Compounded semaglutide billed monthly: $159 at 0.25 mg/week (month 1), $199 at 0.50 mg, $229 at 1.0 mg, $249 at 1.7 mg and $249 at 2.4 mg · compounded tirzepatide $239 at 2.5 mg rising to $439 at 15 mg · a separate three-month same-dose plan prepays the 0.25 mg rung at $115/mo ($345 upfront) · stated on the page as "Billed monthly" with "No subscription required"
- Vs median
- $10/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Quotes off the lowest dose
States plainly that its advertised figures are based on the lowest dosage and that higher doses may cost more. On a general ranking that is a warning; for someone staying small it is the one model that bills accordingly.
36 of the 373 programs we track price a small dose this way. A genuine per-dose ladder: the row records four semaglutide price bands rising with the dose, each carrying its own milligram figure, and the cheapest band is the lowest dose. The month-to-month tab states 'Billed monthly' and 'No subscription required', so the readable figure is a standing rate rather than a prepay rung. The struck-through comparison beside the entry price is the NEXT dose band's price, which is why the advertised saving is not treated as a discount here.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Charges by the dose rather than one flat rate, so a patient who stays low actually pays less — $159 at 0.25 mg/week against $249 at 2.4 mg
- Publishes a milligram figure against every price rung on both molecules, which most providers here do not
- The month-to-month option is genuinely month-to-month: the page states "Billed monthly" and "No subscription required", so the headline rate is not a prepay rung
- A three-month same-dose plan lowers the 0.25 mg rate further, to $115/mo, for a patient who already knows they intend to stay low
- The first dose band is the cheapest one, so the entry price and the low-dose price are the same number — the reverse of the usual promo structure
Pharmacy, labs and oversight
Coby Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Coby Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Coby Health is a direct-to-consumer telehealth brand selling compounded semaglutide and compounded tirzepatide as once-weekly self-injections, with the intake and ongoing support handled online. What distinguishes it here is the pricing structure: rather than one figure for every dose, Coby publishes a rung for each dose band and charges less for the lower ones, so a patient who stays at 0.25 mg/week pays $159 while one who titrates to 2.4 mg pays $249. It offers the same ladder twice — a month-to-month tab billed monthly, and a three-month same-dose bundle that prepays a lower rate. No compounding pharmacy is named anywhere anywhere on its public pages.
The honest cons
The bundle block advertises "Starts at $199 $159", but $199 is not a former price of the 0.25 mg rung — it is what Coby charges for the NEXT dose up, 0.50 mg. The saving is displayed against a higher dose than the one being sold
- The terms state in capitals that "ANY APPLICABLE FEES AND OTHER CHARGES ARE NOT REFUNDABLE IN WHOLE OR IN PART", which sits awkwardly against the "No subscription required" framing on the product page — you can stop reordering, but you cannot get money back
- Five FAQ answers on the semaglutide page still contain placeholder Lorem ipsum text, including the answer to "Does Coby require a subscription?" — the question a reader most needs answered
- The terms of service are linked from the footer at /policies/terms-of-service while /terms-of-service leads nowhere page, so the obvious URL leads nowhere
- No compounding pharmacy is named on any page checked
- The three-month plan is prepaid, so the $115/mo rate requires $345 upfront against terms that make it non-refundable
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Coby Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#74 of 373
Ordered with the companies that pay us first, and Coby Health is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Low dose vs full dose
- Microdose & reconstitution calculator
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Elara MD
$249/mo at 0.2 mg/wk semaglutide
- Vs median
- $80/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Quotes off the lowest dose
- Dispensed
- Compounded, 503A pharmacy
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Elara MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.